Single-dose intravenous iron infusion or oral iron for treatment of fatigue after postpartum haemorrhage: a randomized controlled trial

Vox Sanguinis

Volumn 112, Issue 3, 2017, Pages 219-228

  Holm, C ^a,b   Thomsen, L L ^b   Norgaard, A ^a   Langhoff Roos, J ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Pharmacosmos AS   (Denmark)

Author keywords

anaemia; intravenous iron; iron deficiency; iron isomaltoside; postpartum fatigue; postpartum haemorrhage

Indexed keywords

IRON; IRON ISOMALTOSIDE; UNCLASSIFIED DRUG; HEMOGLOBIN;

ADULT; ARTICLE; BREAST FEEDING; CONNECTIVE TISSUE DISEASE; CONSTIPATION; CONTROLLED STUDY; DEPRESSION; EDINBURGH POSTNATAL DEPRESSION SCALE; ERYTHROCYTE TRANSFUSION; FATIGUE; FEMALE; FEVER; HEMORRHOID; HUMAN; INFUSION RELATED REACTION; INJECTION SITE DISCOLORATION; INJECTION SITE IRRITATION; MAJOR CLINICAL STUDY; MILK PRODUCTION; MULTIDIMENSIONAL FATIGUE INVENTORY; MUSCULOSKELETAL DISEASE; MYALGIA; ORAL PARESTHESIA; PAIN; PATIENT-REPORTED OUTCOME; PHLEBITIS; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; VASCULAR DISEASE; ANEMIA, IRON-DEFICIENCY; AREA UNDER THE CURVE; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PATHOLOGY; PREGNANCY; PUERPERIUM; RECEIVER OPERATING CHARACTERISTIC; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; ANEMIA, IRON-DEFICIENCY; AREA UNDER CURVE; FATIGUE; FEMALE; HEMOGLOBINS; HUMANS; INFUSIONS, INTRAVENOUS; IRON; POSTPARTUM HEMORRHAGE; POSTPARTUM PERIOD; PREGNANCY; ROC CURVE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 85013158265     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12477     Document Type: Article

References (31)

1. LeeKA, ZaffkeME: Longitudinal changes in fatigue and energy during pregnancy and the postpartum period. J Obstet Gynecol Neonatal Nurs 1999; 28:183–191
2. BodnarLM, CogswellME, McDonaldT: Have we forgotten the significance of postpartum iron deficiency?Am J Obstet Gynecol 2005; 193:36–44
3. KrafftA, PerewusnykG, HanselerE, et al.: Effect of postpartum iron supplementation on red cell and iron parameters in non-anaemic iron-deficient women: a randomised placebo-controlled study. Br J Obstet Gynaecol 2005; 112:445–450
4. Sundhedsstyrelsen. National klinisk retningslinje om indikation for transfusion med blodkomponenter [Internet]. Copenhagen: Sundhedsstyrelsen; 2014. Available from Sundhedss tyrelsen: https://sundhedsstyrelsen.dk/da/udgivelser/2014/~/media/EEA1EA90C15E4A97B9E786D2850B3664.ashx [Last accessed 5 November 2015]
5. MerinoSG, PicadoAL, HernándezHM, et al.: Ensayo clínico aleatorizado para evaluar la efectividad de dos vías de administración de hierro, oral e intravenosa, en el tratamiento de la anemia ferropénica posparto. Clínica Investigación Ginecol Obstetricia 2012; 39:190–195 [in Spanish]
6. WestadS, BackeB, SalvesenKÅ, et al.: A 12-week randomised study comparing intravenous iron sucrose versus oral ferrous sulphate for treatment of postpartum anemia. Acta Obstet Gynecol Scand 2008; 87:916–923
7. BhandalN, RussellR: Intravenous versus oral iron therapy for postpartum anaemia. Br J Obstet Gynaecol 2006; 113:1248–1252
8. Van WyckDB, MartensMG, SeidMH, et al.: Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial. Obstet Gynecol 2007; 110:267–278
9. SeidMH, DermanRJ, BakerJB, et al.: Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial. Am J Obstet Gynecol 2008; 199:435.e1-7
10. BreymannC, GligaF, BejenariuC, et al.: Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia. Int J Gynaecol Obstet 2008; 101:67–73
11. VermaS, InamdarSA, MalhotraN: Intravenous iron therapy versus oral iron in postpartum patients in rural area. J SAFOG 2011; 3:67–70
12. FroesslerB, CocchiaroC, Saadat-GilaniK, et al.: Intravenous iron sucrose versus oral iron ferrous sulfate for antenatal and postpartum iron deficiency anemia: a randomised trial. J Matern Fetal Neonatal Med 2013; 26:654–659
13. JainG, PalariaU, JhaSK: Intravenous iron in postpartum anemia. J Obstet Gynecol India 2013; 63:45–48
14. MumtazA, FarooqF: Comparison for effects of intravenous versus oral iron therapy for postpartum anemia. Pak J Med Health Sci 2011; 5:116–120
15. MarkovaV, NorgaardA, JørgensenKJ, et al. Treatment for women with postpartum iron deficiency anaemia. Cochrane Database Syst Rev 2015; (8):CD010861
16. HolmC, ThomsenLL, NorgaardA, et al.: Intravenous iron isomaltoside 1000 administered by high single-dose infusions or standard medical care for the treatment of fatigue in women after postpartum haemorrhage: study protocol for a randomised controlled trial. Trials 2015; 16:5
17. National Board of Health. Healthy habits – before, during and after pregnancy [Internet]. Copenhagen: Sundhedsstyrelsen; 2010. Available from Sundhedsstyrelsen: http://sundhedsstyrelsen.dk/~/media/CB2593468DF446C6B0A62868F72DEDAE.ashx [Last accessed 5 November 2015]
18. SmetsEM, GarssenB, BonkeB, et al.: The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995; 39:315–325
19. CoxJL, HoldenJM, SagovskyR: Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 1987; 150:782–786
20. JansenAJ, Essink-BotM, BeckersEA, et al.: Quality of life measurement in patients with transfusion-dependent myelodysplastic syndromes. Br J Haematol 2003; 121:270–274
21. JansenAJ, Essink-BotM-L, DuvekotJJ, et al.: Psychometric evaluation of health-related quality of life measures in women after different types of delivery. J Psychosom Res 2007; 63:275–281
22. GibsonJ, McKenzie-McHargK, ShakespeareJ, et al.: A systematic review of studies validating the Edinburgh Postnatal Depression Scale in antepartum and postpartum women. Acta Psychiatri Scand 2009; 119:350–364
23. MilmanN: Postpartum anemia I: definition, prevalence, causes, and consequences. Ann Hematol 2011; 90:1247–1253
24. TurawaEB, MusekiwaA, RohwerAC. Interventions for preventing postpartum constipation. Turawa EB. Cochrane Database Syst Rev 2015; (9):CD011625
25. KouryMJ, PonkaP: New insights into erythropoiesis: the roles of folate, vitamin B 12, and Iron. 1. Annu Rev Nutr 2004; 24:105–131
26. FishbaneS, UngureanuVD, MaesakaJK, et al.: The safety of intravenous iron dextran in hemodialysis patients. Am J Kidney Dis 1996; 28:529–534
27. AuerbachM, BallardH, GlaspyJ: Clinical update: intravenous iron for anaemia. Lancet 2007; 369:1502–1504
28. RamptonD, FolkersenJ, FishbaneS, et al.: Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management. Haematologica 2014; 99:1671–1676
29. DeLougheryTG, AuerbachM: Is low-molecular weight iron dextran really the most risky iron? - Unconvincing data from an unconvincing study. Am J Hematol 2016; 91:451–452
30. Van WyckDB, MangioneA, MorrisonJ, et al.: Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial. Transfusion 2009; 49:2719–2728
31. Food and Drug Administration Center for Drug Evaluation and Research. Summary minutes of the drug safety and risk management advisory committee [Internet]. Maryland: Food and Drug Administration; 2008. Available from Fodd and Drug Administration: http://www.fda.gov/ohrms/dockets/AC/08/minutes/2008-4337m1-Final.pdf [Last accessed 1 October 2016]